OREGA will present latest in vivo data of its IL-17B program at the upcoming AACR annual conference to be held in Washington DC.

SESSION PO.IM02.06 – Cytokines: The First Modern Immunotherapies

April 3, 2017, 8:00 AM – 12:00 PM

1602 / 10 – Generation of anti-IL-17B antibodies neutralizing IL-17B-mediated alterations of the immune microenvironment, promotion of tumor cell initiating capacity and chemoresistance